Australia's Hydration Pharma rises on Canada's nod for production
** Shares of Hydration Pharmaceutical Co Ltd HPC.AX rise
as much as 8.3% to A$0.13, their highest since Nov. 7
** Consumer products co says receives Health Canada nod to
start production of Hydralyte liquid product range urn:newsml:reuters.com:*:nASX65D9qM
** Says Oct total net sales surges 125% yoy, to $925,000
** Over 127,500 shares trade hand vs 30-day avg of 64,990
** Stock down 60% YTD as of last close
(Reporting by John Biju in Bengaluru)
((John.Biju@thomsonreuters.com;))
Recent news on Hydration Pharmaceuticals
See all newsBrief: Hydration Pharmaceuticals Launches Pro Rata Entitlement Offer To Raise Up To A$1.43 MLN
Australia's Hydration Pharmaceuticals soars on upbeat monthly sales
Australia's Hydration Pharmaceuticals soars 144% on asset sale to US co
Brief: Hydration Pharmaceuticals Announces Divesture Of Hydralyte's Non-US Assets
Brief: Hydration Pharmaceuticals Says Adem Karafili Appointed Non-Executive Chairman